Literature DB >> 22832848

Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.

Ruchadaporn Kaomongkolgit1.   

Abstract

The purpose of this study was to investigate the effect of alpha-mangostin on matrix metalloproteinase (MMP)-2 and MMP-9 expression in head and neck squamous cell carcinoma (HNSCC). The human HNSCC cell lines were treated with alpha-mangostin and the cytotoxicity of alpha-mangostin in HNSCC was determined using the MTS assay. To determine the effect of alpha-mangostin on the expression of MMP-2 and MMP-9 in HNSCC, gelatin zymography and RT-PCR were performed. The results showed that alpha-mangostin increased in growth inhibition of HNSCC cell lines in a concentration-dependent manner. Treatment with alpha-mangostin decreased MMP-2 and MMP-9 expression in a concentration-dependent manner in all cell lines. These findings suggested that alpha-mangostin might be a potential therapeutic agent for HNSCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832848     DOI: 10.1007/s10266-012-0081-2

Source DB:  PubMed          Journal:  Odontology        ISSN: 1618-1247            Impact factor:   2.634


  18 in total

1.  Global cancer statistics.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

Review 2.  Molecular parameters of head and neck cancer metastasis.

Authors:  Sanjay L Bhave; Theodoras N Teknos; Quintin Pan
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

3.  Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.

Authors:  Constanze Ondruschka; Peter Buhtz; Christiane Motsch; Bernd Freigang; Regine Schneider-Stock; Albert Roessner; Carsten Boltze
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

Review 4.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

5.  α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth.

Authors:  Jeremy J Johnson; Sakina M Petiwala; Deeba N Syed; John T Rasmussen; Vaqar M Adhami; Imtiaz A Siddiqui; Amanda M Kohl; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2011-12-09       Impact factor: 4.944

6.  Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.

Authors:  Yuan-Wei Shih; Shang-Tao Chien; Pin-Shern Chen; Jian-Hui Lee; Shu-Hau Wu; Li-Te Yin
Journal:  Cell Biochem Biophys       Date:  2010-09       Impact factor: 2.194

Review 7.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

8.  alpha-Mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells.

Authors:  Yuan-Bing Lee; Kung-Chung Ko; Ming-Der Shi; Yi-Chen Liao; Tai-An Chiang; Pei-Fen Wu; You-Xin Shih; Yuan-Wei Shih
Journal:  J Food Sci       Date:  2010 Jan-Feb       Impact factor: 3.167

9.  Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells.

Authors:  Yoshihito Nakagawa; Munekazu Iinuma; Tomoki Naoe; Yoshinori Nozawa; Yukihiro Akao
Journal:  Bioorg Med Chem       Date:  2007-05-18       Impact factor: 3.641

10.  α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation.

Authors:  Masa-Aki Shibata; Munekazu Iinuma; Junji Morimoto; Hitomi Kurose; Kanako Akamatsu; Yasushi Okuno; Yukihiro Akao; Yoshinori Otsuki
Journal:  BMC Med       Date:  2011-06-03       Impact factor: 8.775

View more
  8 in total

1.  Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.

Authors:  Pamela D Thompson; Amos Sakwe; Rainelli Koumangoye; Wendell G Yarbrough; Josiah Ochieng; Dana R Marshall
Journal:  Exp Cell Res       Date:  2013-12-12       Impact factor: 3.905

2.  Inhibitory effect of alpha-mangostin on Candida biofilms.

Authors:  Ruchadaporn Kaomongkolgit; Kusuma Jamdee
Journal:  Odontology       Date:  2016-07-01       Impact factor: 2.634

3.  Alpha-mangostin suppresses IL-6 and IL-8 expression in P. gingivalis LPS-stimulated human gingival fibroblasts.

Authors:  Ichaya Yiemwattana; Ruchadaporn Kaomongkolgit
Journal:  Odontology       Date:  2014-06-03       Impact factor: 2.634

4.  α-Mangostin Induces Apoptosis and Cell Cycle Arrest in Oral Squamous Cell Carcinoma Cell.

Authors:  Hyun-Ho Kwak; In-Ryoung Kim; Hye-Jin Kim; Bong-Soo Park; Su-Bin Yu
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-12       Impact factor: 2.629

5.  Inhibitory Effect of Alpha-Mangostin on Adhesion of Candida albicans to Denture Acrylic.

Authors:  Ruchadaporn Kaomongkolgit; Kusuma Jamdee
Journal:  Open Dent J       Date:  2015-12-11

6.  Garcinone E induces apoptosis and inhibits migration and invasion in ovarian cancer cells.

Authors:  Xiao-Huang Xu; Qian-Yu Liu; Ting Li; Jian-Lin Liu; Xin Chen; Li Huang; Wen-An Qiang; Xiuping Chen; Yitao Wang; Li-Gen Lin; Jin-Jian Lu
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

7.  Induction of Apoptosis and Inhibition of Epithelial Mesenchymal Transition by α-Mangostin in MG-63 Cell Lines.

Authors:  Sung-Jin Park; Bong-Soo Park; Su-Bin Yu; Hae-Mi Kang; Hye-Jin Kim; In-Ryoung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-26       Impact factor: 2.629

8.  Stimuli-responsive drug delivery systems for head and neck cancer therapy.

Authors:  Jingou Liang; Bina Yang; Xuedong Zhou; Qi Han; Jing Zou; Lei Cheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.